Fig. 1.

Subject disposition flowchart. ^aPlanned enrollment was 150 subjects. The primary reason that 150 was not achieved was that subjects were ineligible because they chose to delay repeat treatment beyond the window allowed in the Juvéderm follow-up study protocol. ^bThe primary reason for subjects not re-enrolling in the extended portion of the Juvéderm follow-up study was that they had already passed the 6-month timepoint when the protocol amendment was implemented